These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3497436)

  • 1. Trimethoprim used for selective decontamination of the digestive tract in rats: possible route of excretion.
    Toorop-Bouma AG; van der Waaij D
    Scand J Infect Dis; 1987; 19(3):361-7. PubMed ID: 3497436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective elimination of Enterobacteriaceae species from the digestive tract in mice and rats.
    Koopman JP; Kennis HM; Stadhouders AM; de Boer H
    Z Versuchstierkd; 1984; 26(5):197-204. PubMed ID: 6334949
    [No Abstract]   [Full Text] [Related]  

  • 3. Selective decontamination of the digestive tract of pregnant rabbits: a method for producing Enterobacteriaceae-free rabbits.
    Heidt PJ; Timmermans CP
    Lab Anim Sci; 1975 Oct; 25(5):594-6. PubMed ID: 127074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Present status of the resistance of enterobacteria to the combination of a sulfonamide and trimethoprim].
    Riou B; Richard C; Rimailho A; Bottineau G; Coquin Y; Auzepy P
    Presse Med; 1984 Jun; 13(26):1637-8. PubMed ID: 6234571
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of a novel trimethoprim-sulfamethoxazole-containing medium (XT80) with kanamycin agar for isolation of antibiotic-resistant organisms from stool and rectal cultures of marrow transplant patients.
    Hamilton DJ; Ulness BK; Baugher LK; Counts GW
    J Clin Microbiol; 1987 Oct; 25(10):1886-90. PubMed ID: 3312287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective elimination of Enterobacteriaceae from the digestive tract in rats with trimethoprim.
    Koopman JP; Kennis HM; Stadhouders AM; de Boer H; Hectors MP
    Z Versuchstierkd; 1985; 27(3-4):143-8. PubMed ID: 4050161
    [No Abstract]   [Full Text] [Related]  

  • 8. Trimethoprim-sulfamethoxazole for bacterial meningitis.
    Levitz RE; Quintiliani R
    Ann Intern Med; 1984 Jun; 100(6):881-90. PubMed ID: 6372565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.
    Toivanen A; Kasan A; Sundquist H; Toivanen P
    Chemotherapy; 1976; 22(2):97-103. PubMed ID: 1253636
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding to faeces and influence on human anaerobes of antimicrobial agents used for selective decontamination.
    Hazenberg MP; Van de Boom M; Bakker M; Van de Merwe JP
    Antonie Van Leeuwenhoek; 1983 Jun; 49(2):111-7. PubMed ID: 6351739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-trimoxazole resistance in Jamaica.
    Macfarlane DE
    Lancet; 1986 Apr; 1(8486):923. PubMed ID: 2870396
    [No Abstract]   [Full Text] [Related]  

  • 12. Influence of cefaclor, phenethicillin, co-trimoxazole and doxycycline on colonization resistance in healthy volunteers.
    Vollaard EJ; Clasener HA; van Griethuysen AJ; Janssen AJ; Sanders-Reijmers AH; Muller NF; Huige PJ
    J Antimicrob Chemother; 1988 Nov; 22(5):747-58. PubMed ID: 3145269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activity of cefetamet (Ro 15-8074).
    Mittermayer H
    Eur J Clin Microbiol; 1986 Oct; 5(5):530-4. PubMed ID: 3490975
    [No Abstract]   [Full Text] [Related]  

  • 14. [Susceptibility of gram negative bacteria to TMP-SMX and ofloxacin].
    Unal S; Aydin M; Akin A
    Mikrobiyol Bul; 1988; 22(4):316-21. PubMed ID: 3266971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trimethoprim-sulfamethoxazole.
    Rubin RH; Swartz MN
    N Engl J Med; 1980 Aug; 303(8):426-32. PubMed ID: 6967184
    [No Abstract]   [Full Text] [Related]  

  • 16. Therapeutic progress: trimethoprim-sulfamethoxazole.
    Ruiz López R; Saavedra S; Ramírez-Ronda CH
    Bol Asoc Med P R; 1984 Jul; 76(7):309-13. PubMed ID: 6332635
    [No Abstract]   [Full Text] [Related]  

  • 17. Infection caused by thymidine-requiring, trimethoprim-resistant bacteria.
    King CH; Shlaes DM; Dul MJ
    J Clin Microbiol; 1983 Jul; 18(1):79-83. PubMed ID: 6604070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cotrimoxazole on the absorption of orally administered 6-mercaptopurine in the rat.
    Burton NK; Aherne GW
    Cancer Chemother Pharmacol; 1986; 16(1):83-4. PubMed ID: 3484383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of a combined preparation of trimethoprim and sulphamethoxazole following short-term and long-term administration on the flora of the human gut.
    Knothe H
    Chemotherapy; 1973; 18(5):285-96. PubMed ID: 4199490
    [No Abstract]   [Full Text] [Related]  

  • 20. Emergence of high-level trimethoprim resistance in fecal Escherichia coli during oral administration of trimethoprim or trimethoprim--sulfamethoxazole.
    Murray BE; Rensimer ER; DuPont HL
    N Engl J Med; 1982 Jan; 306(3):130-5. PubMed ID: 7033781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.